[eGongsi Notice] KOSDAQ -11th

[Asia Economy Reporter Ji Yeon-jin]

◆ Telechips = Q3 sales KRW 36.5 billion (+59.7%), operating profit KRW 2.1 billion (turned profitable), net profit KRW 2.8 billion (turned profitable)

◆ YG Entertainment = Q3 sales KRW 85.9 billion (+31.2%), operating profit KRW 17.3 billion (+370.7%), net profit KRW 0.5 billion (-64.3%)

◆ Seegene = Q3 sales KRW 305.3 billion (-6.6%), operating profit KRW 128.6 billion (-38.7%), net profit KRW 93.2 billion (-38.9%), cash dividend of KRW 200 per share decided.

◆ Mecaro = New facility investment for development and commercialization of ceramic heater blocks and ESC worth KRW 10 billion.

◆ DK&D = Decided a bonus issue of 1 new share per 1 existing share.

◆ Humax = Q3 sales KRW 157.3 billion (-27.5%), operating loss KRW 7 billion (-146.7%), net loss KRW 4.4 billion (+70.1%)

◆ NHN Korea Cyber Payment = Decided a bonus issue of 0.5 new shares per 1 existing share.

◆ Osstem Implant = Decided a paid-in capital increase worth KRW 20 billion for debt repayment and others.

◆ Pharma Research = The Ministry of Food and Drug Safety (MFDS) of Seoul issued a provisional manufacturing suspension order for Rientox 100 units per week of subsidiary Pharma Research Bio.

◆ Hyundai Bio = MFDS approved phase 1 clinical trial plan for COVID-19 treatment.

◆ Hugel = Seoul Administrative Court suspended the effect of MFDS’s provisional manufacturing and sales suspension order on Botulax product until November 26.

This content was produced with the assistance of AI translation services.